To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Departmental Publication (Transparency)
Home Office

Apr. 12 2024

Source Page: Non-technical summaries granted in 2024
Document: Non-technical summaries: projects granted in 2024, January to March (PDF)

Found: stem cell therapies for neurodegenerative and neovascular conditions in the eye and brain, and there

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/774 - attachment 1 (PDF)

Found: cellular immune responses.

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/774 - attachment 2 (PDF)

Found: cellular immune responses.

Written Question
Gene Therapies: Innovation
Tuesday 20th February 2024

Asked by: Jim Shannon (Democratic Unionist Party - Strangford)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will make an assessment of developing a cross-departmental strategy including the (a) Department for Science, Innovation and Technology and (b) NHS to (i) support and (ii) promote expertise in cell and gene therapy innovation.

Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department recognises that advanced cell and gene therapies will be an important part of the future of healthcare and the life sciences industry. The Department has been considering the recommendations of the National Cell and Gene Therapy Vision for the UK, a report published by the Cell and Gene Therapy Catapult in March 2022, and the UK Strategic Stem Cell Forum’s latest report, A 10 Year Vision for Stem Cell Transplantation and Advanced Cellular Therapies, published in July 2022. As part of this we have been conducting stakeholder engagement across the cell and gene therapy ecosystem to further understand the challenges raised and whether there is a role for the Department in coordinating activity in this area. We will continue to work with our public sector partners to ensure a whole system approach to advanced therapies, building on existing strengths to ensure a joined-up research, regulatory, and health ecosystem.

Select Committee
First Report - The antimicrobial potential of bacteriophages

Report Jan. 03 2024

Committee: Science, Innovation and Technology Committee

Found: Lytic phages involves a virus taking control of a host bacterial cell and using it to produce its viral

Non-Departmental Publication (Guidance and Regulation)
Advisory Committee on Clinical Impact Awards

Nov. 28 2023

Source Page: Clinical Impact Awards 2022: personal statements
Document: Personal statements from new Clinical Impact Award holders in the 2022 round (PDF)

Found: cell, CAR- T & cord blood trials & nationally commissioned stem cell & gene therapies. 3) As trust

Written Question
UK Stem Cell Strategic Forum
Tuesday 28th November 2023

Asked by: Jackie Doyle-Price (Conservative - Thurrock)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if she will review the (a) terms of reference and (b) governance of the UK Stem Cell strategic forum.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The terms of reference and governance of the UK Stem Cell Strategic Forum are reviewed periodically and on an ad hoc basis as required. The Forum published its latest report A 10 Year Vision for Stem Cell Transplantation and Advanced Cellular Therapies in July 2022 to address weaknesses in stem cell transplantation services. The Forum is working with the Department, NHS England, NHS Blood and Transplant, clinicians, industry, and representatives of patient groups to take the recommendations forward. An oversight committee and five working groups have been established in line with the current terms of reference.

Written Question
Stem Cells: Donors
Tuesday 28th November 2023

Asked by: Jackie Doyle-Price (Conservative - Thurrock)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential merits of increasing self-sufficiency in UK stem cell donations.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The UK Stem Cell Strategic Forum, a Departmental advisory body, has recommended in its report A 10 Year Vision for Stem Cell Transplantation and Advanced Cellular Therapies that donor to patient unrelated donations in the United Kingdom should be increased to 45%. This will improve the sustainability and resilience of UK stem cell supply, maintain the UK’s expertise in stem cell provision and support adoption of advanced cellular therapies. The Department is investing £2.4 million between April 2022 and March 2025 to recruit stem cell donors to improve resilience and help address health inequalities.

Departmental Publication (Transparency)
Home Office

Jul. 20 2023

Source Page: Non-technical summaries granted in 2023
Document: Non-technical summaries: projects granted in 2023, January to March (PDF)

Found: The current project has the overarching aim of developing stem cell therapies for the treatment of inner

Departmental Publication (Transparency)
Home Office

Jul. 20 2023

Source Page: Non-technical summaries granted in 2023
Document: Non-technical summaries: projects granted in 2023, April to June (PDF)

Found: cells, Gene Regulation, Stem Cell self-renewal, Stem cell niche, Organoids Animal types